The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making

References

• Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):540–546. doi:10.7326/M19-1208
   PubMed Web of Science ®Google Scholar
• Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia. Haemophilia. 2020;26(S6):1–158. doi:10.1111/hae.14046
   PubMed Web of Science ®Google Scholar
• Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev. 2021;1:100890. doi:10.1016/j.blre.2021.100890
   Web of Science ®Google Scholar
• Knobe K, Berntorp E. Haemophilia and joint disease: pathophysiology, evaluation, and management. J Comorbidity. 2011;1(1):51–59. doi:10.15256/joc.2011.1.2
   PubMedGoogle Scholar
• Aledort L, Mannucci PM, Schramm W, Tarantino M. Factor VIII replacement is still the standard of care in haemophilia A. Blood Transfus. 2019;17(6):479–486. doi:10.2450/2019.0211-19
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Hemophilia therapy: the future has begun. Haematologica. 2020;105(3):545–553. doi:10.3324/haematol.2019.232132
   PubMed Web of Science ®Google Scholar
• Pipe SW. Delivering on the promise of gene therapy for haemophilia. Haemophilia. 2021;27(S3):114–121. doi:10.1111/hae.14027
   PubMed Web of Science ®Google Scholar
• Batty P, Lillicrap D. Hemophilia gene therapy: approaching the first licensed product. HemaSphere. 2021;5(3). doi:10.1097/HS9.0000000000000540
   PubMed Web of Science ®Google Scholar
• Perrin GQ, Herzog RW, Markusic DM. Update on clinical gene therapy for hemophilia. Blood. 2019;133(5):407–414. doi:10.1182/blood-2018-07-820720
   PubMed Web of Science ®Google Scholar
• Aiyegbusi OL, Macpherson K, Elston L, et al. Patient and public perspectives on cell and gene therapies: a systematic review. Nat Commun. 2020;11(1):6265. doi:10.1038/s41467-020-20096-1
   PubMed Web of Science ®Google Scholar
• Casey GA, Papp KM, MacDonald IM. Ocular gene therapy with adeno-associated virus vectors: current outlook for patients and researchers. J Ophthalmic Vis Res. 2020;15(3):396–399. doi:10.18502/jovr.v15i3.7457
   PubMed Web of Science ®Google Scholar
• Horgan D, Bolanos N, Mastris K, Mendao L, Malats N. Health literacy: read all about it. Biomed Hub. 2017;2(Suppl 1):44–47. doi:10.1159/000481129
   PubMedGoogle Scholar
• Yeoman G, Furlong P, Seres M, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innovations. 2017;3(2):76. doi:10.1136/bmjinnov-2016-000157
   PubMedGoogle Scholar
• Safeer RS, Keenan J. Health literacy: the gap between physicians and patients. Am Fam Physician. 2005;72(3):463–468.
   PubMed Web of Science ®Google Scholar
• Carpenter DM, Geryk LL, Chen AT, Nagler RH, Dieckmann NF, Han PKJ. Conflicting health information: a critical research need. Health Expect. 2016;19(6):1173–1182. doi:10.1111/hex.12438
   PubMed Web of Science ®Google Scholar
• Suarez-Lledo V, Alvarez-Galvez J. Prevalence of health misinformation on social media: systematic review. J Med Internet Res. 2021;23(1):e17187. doi:10.2196/17187
   PubMed Web of Science ®Google Scholar
• DeFrank JT, Berkman ND, Kahwati L, Cullen K, Aikin KJ, Sullivan HW. Direct-to-consumer advertising of prescription drugs and the patient-prescriber encounter: a systematic review. Health Commun. 2020;35(6):739–746. doi:10.1080/10410236.2019.1584781
   PubMed Web of Science ®Google Scholar
• Hersh L, Salzman B, Snyderman D. Health literacy in primary care practice. Am Fam Physician. 2015;92(2):118–124.
   PubMed Web of Science ®Google Scholar
• Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW. Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics. 2011;14(4–5):279–289. doi:10.1159/000294191
   PubMed Web of Science ®Google Scholar
• Gringeri A, Doralt J, Valentino LA, Crea R, Reininger AJ. An innovative outcome-based care and procurement model of hemophilia management. Expert Rev Pharmacoecon Outcomes Res. 2016;16(3):337–345. doi:10.1080/14737167.2016.1178066
   PubMed Web of Science ®Google Scholar
• Miesbach W, O’Mahony B, Key NS, Makris M. How to discuss gene therapy for haemophilia? A patient and physician perspective. Haemophilia. 2019;25(4):545–557. doi:10.1111/hae.13769
   PubMed Web of Science ®Google Scholar
• Valentino LA, Blanchette V, Negrier C, et al. Personalising haemophilia management with shared decision making. J Haemophilia Practice. 2021;8(1):69–79. doi:10.17225/jhp00178
   Google Scholar
• Kunneman M, Montori VM. When patient-centred care is worth doing well: informed consent or shared decision-making. BMJ Qual Saf. 2017;26(7):522–524. doi:10.1136/bmjqs-2016-005969
   PubMed Web of Science ®Google Scholar
• Hart DP, Branchford BR, Hendry S, et al. Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study. Orphanet J Rare Dis. 2021;16(1):189. doi:10.1186/s13023-020-01555-w
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences E, and Medicine; Health and Medicine; Division; Board on Population Health and Public Health Practice; Roundtable on Health Literacy; Alexis Wojtowicz and Melissa G. French, Rapporteurs. The National Academies Collection: reports funded by National Institutes of Health. In: French MG, Wojtowicz A, editors. Health Literacy in Clinical Research: Practice and Impact: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2020.
   Google Scholar
• NHF. Frequently Asked Questions. Available from: https://www.hemophilia.org/bleeding-disorders-A-z/treatment/future-therapies/frequently-asked-questions. Accessed December 2021.
   Google Scholar
• Laferton JAC, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol. 2017;8:233. doi:10.3389/fpsyg.2017.00233
   PubMed Web of Science ®Google Scholar
• Pierce GF, Coffin D. Members of the WFHGTRTPC, Organizing C. The 1st WFH Gene Therapy Round Table: understanding the landscape and challenges of gene therapy for haemophilia around the world. Haemophilia. 2019;25(2):189–194. doi:10.1111/hae.13673
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Lillicrap D, Mahlangu J, et al. Hemophilia gene therapy knowledge and perceptions: results of an international survey. Res Pract Thromb Haemost. 2020;4(4):644–651. doi:10.1002/rth2.12326
   PubMed Web of Science ®Google Scholar
• Iorio A, Skinner MW, Clearfield E, et al. Core outcome set for gene therapy in haemophilia: results of the coreHEM multistakeholder project. Haemophilia. 2018;24(4):e167–e172. doi:10.1111/hae.13504
   PubMed Web of Science ®Google Scholar
• van Balen EC, Wesselo ML, Baker BL, et al. Patient perspectives on novel treatments in haemophilia: a qualitative study. Patient. 2020;13(2):201–210. doi:10.1007/s40271-019-00395-6
   PubMedGoogle Scholar
• van Overbeeke E, Michelsen S, Hauber B, et al. Patient perspectives regarding gene therapy in haemophilia: interviews from the PAVING study. Haemophilia. 2021;27(1):129–136. doi:10.1111/hae.14190
   PubMed Web of Science ®Google Scholar
• Sturgis P, Brunton-Smith I, Jackson J. Trust in science, social consensus and vaccine confidence. Nat Human Behav. 2021;5(11):1528–1534. doi:10.1038/s41562-021-01115-7
   PubMed Web of Science ®Google Scholar
• Offit PA, Coffin SE. Communicating science to the public: MMR vaccine and autism. Vaccine. 2003;22(1):1–6. doi:10.1016/s0264-410x(03)00532-2
   PubMed Web of Science ®Google Scholar
• Rush L, Patterson C, McDaid L, Hilton S. Communicating antimicrobial resistance and stewardship in the national press: lessons from sepsis awareness campaigns. J Infect. 2019;78(2):88–94. doi:10.1016/j.jinf.2018.09.001
   PubMed Web of Science ®Google Scholar
• Wise J. Covid-19: how AstraZeneca lost the vaccine PR war. Br Med J. 2021;1:373. doi:10.1136/bmj.n921
   Web of Science ®Google Scholar
• Oliffe M, Thompson E, Johnston J, Freeman D, Bagga H, Wong PKK. Assessing the readability and patient comprehension of rheumatology medicine information sheets: a cross-sectional Health Literacy Study. BMJ Open. 2019;9(2):e024582. doi:10.1136/bmjopen-2018-024582
   PubMed Web of Science ®Google Scholar
• Stossel LM, Segar N, Gliatto P, Fallar R, Karani R. Readability of patient education materials available at the point of care. J Gen Intern Med. 2012;27(9):1165–1170. doi:10.1007/s11606-012-2046-0
   PubMed Web of Science ®Google Scholar
• Khair K, Steadman L, Chaplin S, Holland M, Jenner K, Fletcher S. Parental perspectives on gene therapy for children with haemophilia: the Exigency study. Haemophilia. 2021;27(1):120–128. doi:10.1111/hae.14188
   PubMed Web of Science ®Google Scholar
• Reiss UM, Zhang L, Ohmori T. Hemophilia gene therapy-New country initiatives. Haemophilia. 2021;27 Suppl 3:132–141. doi:10.1111/hae.14080
   PubMed Web of Science ®Google Scholar
• Kaczmarek R, Pierce GF, Noone D, O’Mahony B, Page D, Skinner MW. Eliminating Panglossian thinking in development of AAV therapeutics. Mol Ther. 2021;29(12):3325–3327. doi:10.1016/j.ymthe.2021.10.025
   PubMed Web of Science ®Google Scholar
• Pierce GF. Uncertainty in an era of transformative therapy for haemophilia: addressing the unknowns. Haemophilia. 2021;27(S3):103–113. doi:10.1111/hae.14023
   PubMed Web of Science ®Google Scholar
• Pierce GF, Kaczmarek R, Noone D, O’Mahony B, Page D, Skinner MW. Gene therapy to cure haemophilia: is robust scientific inquiry the missing factor? Haemophilia. 2020;26(6):931–933. doi:10.1111/hae.14131
   PubMed Web of Science ®Google Scholar
• Rosen S, Tiefenbacher S, Robinson M, et al. Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy. Blood. 2020;136(22):2524–2534. doi:10.1182/blood.2020005683
   PubMed Web of Science ®Google Scholar